Sanofi, Generics Failed To Report Ambien IP Deals: FTC
The Federal Trade Commission said on Tuesday that Sanofi-Aventis U.S. LLC and two generic-drug makers violated federal law by failing to report patent infringement pacts that resolved suits over Sanofi's Ambien...To view the full article, register now.
Already a subscriber? Click here to view full article